Roles of the intestinal microbiota in pathogen protection

Clinical and Translational Immunology

Volumn 6, Issue 2, 2017, Pages

  Ubeda, Carles ^a,b   Djukovic, Ana ^a   Isaac, Sandrine ^a  

^a Centro Superior de Investigacion en Salud Publica   (Spain)

^b Network of Biomedical Research in Epidemiology and Public Health (CIBERESP)   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW CELL; COMMENSAL; ETIOLOGY; GASTROINTESTINAL TRACT; HUMAN; IMMUNOCOMPETENT CELL; INNATE LYMPHOID CELL; INTESTINE; INTESTINE FLORA; LYMPHOCYTE; MOUSE; NONHUMAN; PHARMACEUTICS; PREVENTION; REVIEW;

EID: 85057213143     PISSN: None     EISSN: 20500068     Source Type: Journal    
DOI: 10.1038/cti.2017.2     Document Type: Review

References (95)

1. Morgan XC, Huttenhower C. Meta'omic analytic techniques for studying the intestinal microbiome. Gastroenterology 2014; 146: 1437–1448.e1.
2. Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 2010; 120: 4332–4341.
3. Isaac S, Scher JU, Djukovic A, Jiménez N, Littman DR, Abramson SB et al. Short-and long-term effects of oral vancomycin on the human intestinal microbiota. J Antimicrob Chemother 2016; 72: 128–136.
4. Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2014, 517: 205–208.
5. Ubeda C, Pamer EG. Antibiotics, microbiota, and immune defense. Trends Immunol 2012; 33: 459–466.
6. Kommineni S, Bretl DJ, Lam V, Chakraborty R, Hayward M, Simpson P et al. Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract. Nature 2015; 526: 719–722.
7. Zipperer A, Konnerth MC, Laux C, Berscheid A, Janek D, Weidenmaier C et al. Human commensals producing a novel antibiotic impair pathogen colonization. Nature 2016; 535: 511–516.
8. Sassone-Corsi M, Nuccio S-P, Liu H, Hernandez D, Vu CT, Takahashi AA et al. Microcins mediate competition among Enterobacteriaceae in the inflamed gut. Nature 2016; 540: 280–283.
9. Quereda JJ, Dussurget O, Nahori M-A, Ghozlane A, Volant S, Dillies M-A et al. Bacteriocin from epidemic Listeria strains alters the host intestinal microbiota to favor infection. Proc Natl Acad Sci USA 2016; 113: 5706–5711.
10. Shin R, Suzuki M, Morishita Y. Influence of intestinal anaerobes and organic acids on the growth of enterohaemorrhagic Escherichia coli O157:H7. J Med Microbiol 2002; 51: 201–206.
11. Hsiao A, Ahmed AMS, Subramanian S, Griffin NW, Drewry LL, Petri WA et al. Members of the human gut microbiota involved in recovery from Vibrio cholerae infection. Nature 2014; 515: 423–426.
12. Lawhon SD, Maurer R, Suyemoto M, Altier C. Intestinal short-chain fatty acids alter Salmonella typhimurium invasion gene expression and virulence through BarA/SirA. Mol Microbiol 2002; 46: 1451–1464.
13. Gantois I, Ducatelle R, Pasmans F, Haesebrouck F, Hautefort I, Thompson A et al. Butyrate specifically down-regulates Salmonella pathogenicity Island 1 gene expression. Appl Environ Microbiol 2006; 72: 946–949.
14. Theriot CM, Koenigsknecht MJ, Carlson PE, Hatton GE, Nelson AM, Li B et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun 2014; 5: 1–10.
15. Maltby R, Leatham-Jensen MP, Gibson T, Cohen PS, Conway T. Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157:H7 in the mouse intestine. PLoS ONE 2013; 8: e53957.
16. Kamada N, Kim YG, Sham HP, Vallance BA, Puente JL, Martens EC et al. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 2012; 336: 1325–1329.
17. Ng KM, Ferreyra JA, Higginbottom SK, Lynch JB, Kashyap PC, Gopinath S et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013; 502: 96–99.
18. Ferreyra JA, Wu KJ, Hryckowian AJ, Bouley DM, Weimer BC, Sonnenburg JL. Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance. Cell Host Microbe 2014; 16: 770–777.
19. Pacheco AR, Curtis MM, Ritchie JM, Munera D, Waldor MK, Moreira CG et al. Fucose sensing regulates bacterial intestinal colonization. Nature 2012; 492: 113–117.
20. Elliott SJ, Wainwright LA, McDaniel TK, Jarvis KG, Deng YK, Lai LC et al. The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol Microbiol 1998; 28: 1–4.
21. Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol 2014; 14: 141–153.
22. Bergstrom KSB, Kissoon-Singh V, Gibson DL, Ma C, Montero M, Sham HP et al. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog 2010; 6: e1000902.
23. Johansson MEV, Jakobsson HE, Holmén-Larsson J, Schütte A, Ermund A, Rodríguez-Piñeiro AM et al. Normalization of host intestinal mucus layers requires long-term microbial colonization. Cell Host Microbe 2015; 18: 582–592.
24. Frantz AL, Rogier EW, Weber CR, Shen L, Cohen DA, Fenton LA et al. Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides. Mucosal Immunol 2012; 5: 501–512.
25. Brandl K, Plitas G, Schnabl B, Dematteo RP, Pamer EG. MyD88-mediated signals induce the bactericidal lectin RegIII and protect mice against intestinal Listeria monocytogenes infection. J Exp Med 2007; 204: 1891–1900.
26. Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci USA 2008; 105: 20858–20863.
27. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Núñez G et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307: 731–734.
28. Vaishnava S, Yamamoto M, Severson KM, Ruhn KA, Yu X, Koren O et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 2011; 334: 255–258.
29. Cash HL. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006; 313: 1126–1130.
30. Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008; 455: 804–807.
31. Loonen LMP, Stolte EH, Jaklofsky MTJ, Meijerink M, Dekker J, Van Baarlen P et al. REG3γ-deficient mice have altered mucus distribution and increased mucosal inflammatory responses to the microbiota and enteric pathogens in the ileum. Mucosal Immunol 2014; 7: 939–947.
32. Fan D, Coughlin LA, Neubauer MM, Kim J, Kim MS, Zhan X et al. Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat Med 2015; 21: 808–814.
33. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011; 469: 543–547.
34. Karpman D, Loos S, Tati R, Arvidsson I. Haemolytic uraemic syndrome. J Intern Med 2016, 281: 123–148.
35. Bostick JW, Zhou L. Innate lymphoid cells in intestinal immunity and inflammation. Cell Mol Life Sci 2015; 73: 237–252.
36. Sanos SL, Bui VL, Mortha A, Oberle K, Heners C, Johner C et al. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol 2009; 10: 83–91.
37. Kernbauer E, Ding Y, Cadwell K. An enteric virus can replace the beneficial function of commensal bacteria. Nature 2014; 516: 94–98.
38. Fuchs A, Vermi W, Lee JS, Lonardi S, Gilfillan S, Newberry RD et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12-and IL-15-responsive I FN-γ-producing cells. Immunity 2013; 38: 769–781.
39. Lee JS, Cella M, McDonald KG, Garlanda C, Kennedy GD, Nukaya M et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat Immunol 2011; 13: 144–151.
40. Gury-BenAri M, Thaiss CA, Serafini N, Winter DR, Giladi A, Lara-Astiaso D et al. The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome. Cell 2016; 166: 1231–1246.e13.
41. Abt MC, Lewis BB, Caballero S, Xiong H, Carter RA, Sušac B et al. Innate immune defenses mediated by two ILC subsets are critical for protection against acute Clostridium difficile infection. Cell Host Microbe 2015; 18: 27–37.
42. Rankin LC, Girard-Madoux MJH, Seillet C, Mielke LA, Kerdiles Y, Fenis A et al. Complementarity and redundancy of IL-22-producing innate lymphoid cells. Nat Immunol 2015; 17: 179–186.
43. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008; 14: 282–289.
44. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TKA et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010; 464: 1367–1370.
45. Sonnenberg GF, Artis D. Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat Med 2015; 21: 698–708.
46. Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 2013; 39: 372–385.
47. Qiu J, Heller JJ, Guo X, Chen Z-ME, Fish K, Fu Y-X et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 2012; 36: 92–104.
48. Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 2011; 478: 197–203.
49. Khosravi A, Yáñez A, Price JG, Chow A, Merad M, Goodridge HS et al. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe 2014; 15: 374–381.
50. Hasegawa M, Kamada N, Jiao Y, Liu MZ, Nùñez G, Inohara N. Protective role of commensals against Clostridium difficile infection via an IL-1-mediated positive-feedback loop. J Immunol 2012; 189: 3085–3091.
51. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 2010; 16: 228–231.
52. Grainger JR, Wohlfert EA, Fuss IJ, Bouladoux N, Askenase MH, Legrand F et al. Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection. Nat Med 2013; 19: 713–721.
53. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139: 485–498.
54. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122: 107–118.
55. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331: 337–341.
56. Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature 2016; 535: 75–84.
57. Cao AT, Yao S, Gong B, Elson CO, Cong Y. Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis. J Immunol 2012; 189: 4666–4673.
58. Sano T, Huang W, Hall JA, Yang Y, Chen A, Gavzy SJ et al. An IL-23R/IL-22 circuit regulates epithelial serum amyloid A to promote local effector Th17 responses. Cell 2015; 163: 381–393.
59. Atarashi K, Tanoue T, Ando M, Kamada N, Nagano Y, Narushima S et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 2015; 163: 367–380.
60. Kim SV, Xiang WV, Kwak C, Yang Y, Lin XW, Ota M et al. GPR15-mediated homing controls immune homeostasis in the large intestine mucosa. Science 2013; 340: 1456–1459.
61. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H et al. induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013; 500: 232–236.
62. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341: 569–573.
63. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013; 504: 446–450.
64. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013; 504: 451–455.
65. Mortha A, Chudnovskiy A, Hashimoto D, Bogunovic M, Spencer SP, Belkaid Y et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 2014; 343: 1249288–1249288.
66. Cerutti A, Rescigno M. The biology of intestinal immunoglobulin A responses. Immunity 2008; 28: 740–750.
67. Moreau MC, Ducluzeau R, Guy-Grand D, Muller MC. Increase in the population of duodenal immunoglobulin A plasmocytes in axenic mice associated with different living or dead bacterial strains of intestinal origin. Infect Immun 1978; 21: 532–539.
68. Kim M, Qie Y, Park J, Kim CH. Gut microbial metabolites fuel host antibody responses. Cell Host Microbe 2016; 20: 202–214.
69. Zeng MY, Cisalpino D, Varadarajan S, Hellman J, Warren HS, Cascalho M et al. Gut microbiota-induced immunoglobulin G controls systemic infection by symbiotic bacteria and pathogens. Immunity 2016; 44: 647–658.
70. Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, Kremer M et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. Plos Biol 2007; 5: 2177–2189.
71. Levitt MD, Furne J, Springfield J, Suarez F, DeMaster E. Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa. J Clin Invest 1999; 104: 1107–1114.
72. Winter SE, Thiennimitr P, Winter MG, Butler BP, Huseby DL, Crawford RW et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 2010; 467: 426–429.
73. Thiennimitr P, Winter SE, Winter MG, Xavier MN, Tolstikov V, Huseby DL et al. Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proc Natl Acad Sci USA 2011; 108: 17480–17485.
74. Szabó C, Ischiropoulos H, Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 2007; 6: 662–680.
75. Winter SE, Winter MG, Xavier MN, Thiennimitr P, Poon V, Keestra AM et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 2013; 339: 708–711.
76. Raffatellu M, George MD, Akiyama Y, Hornsby MJ, Nuccio S-P, Paixao TA et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 2009; 5: 476–486.
77. Behnsen J, Jellbauer S, Wong CP, Edwards RA, George MD, Ouyang W et al. The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. Immunity 2014; 40: 262–273.
78. Fischbach MA, Lin H, Zhou L, Yu Y, Abergel RJ, Liu DR et al. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci USA 2006; 103: 16502–16507.
79. Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A et al. Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology 2015; 149: 223–237.
80. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407–415.
81. Ubeda C, Bucci V, Caballero S, Djukovic A, Toussaint NC, Equinda M et al. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun 2013; 81: 965–973.
82. Stripling J, Kumar R, Baddley JW, Nellore A, Dixon P, Howard D et al. Loss of vancomycin-resistant Enterococcus fecal dominance in an organ transplant patient with Clostridium difficile colitis after fecal microbiota transplant. Open Forum Infect Dis 2015; 2: ofv078.
83. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012; 148: 1258–1270.
84. Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989; 1: 1156–1160.
85. Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 2012; 8: e1002995.
86. Deriu E, Liu JZ, Pezeshki M, Edwards RA, Ochoa RJ, Contreras H et al. Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe 2013; 14: 26–37.
87. Rea MC, Dobson A, O'Sullivan O, Crispie F, Fouhy F, Cotter PD et al. Effect of broad-and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc Natl Acad Sci USA 2011; 108: 4639–4644.
88. Abt MC, Buffie CG, Sušac B, Becattini S, Carter RA, Leiner I et al. TLR-7 activation enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcus. Sci Transl Med 2016; 8: 327ra25–327ra25.
89. Kinnebrew MA, Ubeda C, Zenewicz LA, Smith N, Flavell RA, Pamer EG. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J Infect Dis 2010; 201: 534–543.
90. Jarchum I, Liu M, Lipuma L, Pamer EG. Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis. Infect Immun 2011; 79: 1498–1503.
91. Schirmer M, Smeekens SP, Vlamakis H, Jaeger M, Oosting M, Franzosa EA et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell 2016; 167: 1125–1136.
92. Lagkouvardos I, Pukall R, Abt B, Foesel BU, Meier-Kolthoff JP, Kumar N et al. The Mouse Intestinal Bacterial Collection (miBC) provides host-specific insight into cultured diversity and functional potential of the gut microbiota. Nat Microbiol 2016; 1: 16131.
93. Browne HP, Forster SC, Anonye BO, Kumar N, Neville BA, Stares MD et al. Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation. Nature 2016; 533: 543–546.
94. Lagier J-C, Khelaifia S, Alou MT, Ndongo S, Dione N, Hugon P et al. Culture of previously uncultured members of the human gut microbiota by culturomics. Nat Microbiol 2016; 1: 1–8.
95. Donia MS, Cimermancic P, Schulze CJ, Brown LCW, Martin J, Mitreva M et al. A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell 2014; 158: 1402–1414.